- Home
- ADUS vs SLNO Comparison
ADUS vs SLNO Comparison
Compare ADUS & SLNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ADUS | SLNO |
|---|---|---|
| Founded | 1979 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Nursing Services | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 2.5B |
| IPO Year | 2009 | 2014 |
Fundamental Metrics
Financial Performance| Metric | ADUS | SLNO |
|---|---|---|
| Price | $108.70 | $46.25 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 11 | 10 |
| Target Price | ★ $138.73 | $110.90 |
| AVG Volume (30 Days) | 163.0K | ★ 1.3M |
| Earning Date | 11-03-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 6.76 | N/A |
| EPS | ★ 4.66 | N/A |
| Revenue | ★ $1,346,596,000.00 | $98,675,000.00 |
| Revenue This Year | $25.50 | N/A |
| Revenue Next Year | $7.11 | $155.86 |
| P/E Ratio | $23.62 | ★ N/A |
| Revenue Growth | ★ 18.77 | N/A |
| 52 Week Low | $88.96 | $41.50 |
| 52 Week High | $136.72 | $90.32 |
Technical Indicators
Market Signals| Indicator | ADUS | SLNO |
|---|---|---|
| Relative Strength Index (RSI) | 36.58 | 38.12 |
| Support Level | $110.12 | $47.01 |
| Resistance Level | $111.57 | $49.75 |
| Average True Range (ATR) | 2.36 | 2.32 |
| MACD | -0.48 | -0.05 |
| Stochastic Oscillator | 5.47 | 2.95 |
Price Performance
Historical ComparisonAbout ADUS Addus HomeCare Corporation
Addus HomeCare Corp is engaged in the provision of in-home personal care services. It operates through the segments such as Personal care segment, which is a key revenue driver, provides non-medical assistance with activities of daily living, mainly to persons who are at risk of hospitalization or institutionalization, such as the elderly, chronically ill and disabled. The Hospice segment provides physical, emotional and spiritual care for people who are terminally ill and their families. Its Home health segment provides services that are medical in nature to those individuals who may require assistance during an illness or after surgery.
About SLNO Soleno Therapeutics Inc.
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.